bioMérieux: turnover of E1.169bn up to 30 June
(CercleFinance.com) - bioMérieux's turnover comes to 1.
169 billion euros as at 30 June 2018, compared to 1.134 billion euros as at 30 June 2017.
Sales grew 10.4% at constant exchange rates and scope.
This growth, reported in euros, continues to be affected by negative translation adjustments of 83 million euros.
In the clinical field, which represented approximately 82% of the Group's total cumulative sales, Q2 2018 turnover came to 474 million euros, up 7.8%. Over the half year, sales came to 961 million euros, up 10.6%.
Turnover for industrial applications, which represents approximately 18% of the Group's sales, was 108 million euros for the 2nd quarter of 2018, up 10.7%. For the first half year, turnover came to 209 million euros, up 9.3%.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
169 billion euros as at 30 June 2018, compared to 1.134 billion euros as at 30 June 2017.
Sales grew 10.4% at constant exchange rates and scope.
This growth, reported in euros, continues to be affected by negative translation adjustments of 83 million euros.
In the clinical field, which represented approximately 82% of the Group's total cumulative sales, Q2 2018 turnover came to 474 million euros, up 7.8%. Over the half year, sales came to 961 million euros, up 10.6%.
Turnover for industrial applications, which represents approximately 18% of the Group's sales, was 108 million euros for the 2nd quarter of 2018, up 10.7%. For the first half year, turnover came to 209 million euros, up 9.3%.
Copyright (c) 2018 CercleFinance.com. All rights reserved.